Page 276«..1020..275276277278..290300..»

Mercator MedSystems Announces Receipt of NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy – Digital…

Posted: Published on January 13th, 2022

EMERYVILLE, CA / ACCESSWIRE / January 10, 2022 / Mercator MedSystems, Inc. (Mercator or the company), announced today that research has begun under a small business technology transfer (STTR) grant for approximately $300,000 funded by the National Institutes of Health (NIH). Preclinical research performed using the grant resources is intended to demonstrate mechanistic effects of local delivery of anti-inflammatory drugs to treat deep vein thrombosis (DVT) Continue reading

Posted in Cardiac Regeneration | Comments Off on Mercator MedSystems Announces Receipt of NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy – Digital…

Rising Focus on Exploring Potential of Stem Cells as Therapeutic Tools in Drug Targeting and Regenerative Medicine to Fuel Revenue Growth of Stem…

Posted: Published on January 13th, 2022

Rapid advancements in stem cell research, development of novel stem cell technology, use of stem cell therapy to treat chronic and rare diseases, and rapid progress of regenerative medicine are some key factors expected to drive market growth NEW YORK, Jan. 10, 2022 /PRNewswire/ -- Reports and Data has published its latest report titled "Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, IPS Cells, and Very Small Embryonic-Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub-Culture), By Therapies (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), and By Application (Regenerative Medicine and Drug Discovery & Discovery), and By Region Forecast To 2028." Reports and Data Logo According to the latest report by Reports and Data, the global stem cells market size was USD 10.13 billion in 2020 and is expected to reach USD 19.31 Billion in 2028 and register a revenue CAGR of 8.4% during the forecast period, 2021-2028. Request a Sample Report https://www.reportsanddata.com/sample-enquiry-form/2981 Drivers, Restraints, & Opportunities Stem cells are cells that have the potential to differentiate into different types of cells in the body Continue reading

Posted in Cardiac Regeneration | Comments Off on Rising Focus on Exploring Potential of Stem Cells as Therapeutic Tools in Drug Targeting and Regenerative Medicine to Fuel Revenue Growth of Stem…

Parkinson’s Treatment Options | Johns Hopkins Medicine

Posted: Published on January 13th, 2022

Parkinson's Disease Specific treatment for a Parkinson's disease will be determined by yourdoctor based on: Your age, overall health, and medical history Extent of the condition Type of condition Your tolerance for specific medications, procedures, or therapies Expectations for the course of the condition Your opinion or preference With today's medicine, we have yet to find a cure for Parkinson's disease. However, based on the severity of the symptoms and medical profile, the doctor will establish an appropriate treatment protocol. Treatment for Parkinson's disease may include the following: Medications Surgery Complementary and supportive therapies, such as diet, exercise, physical therapy, occupational therapy, and speech therapy [6 Medication-Free Ways to Feel Better with Parkinsons Disease] Once the doctor diagnoses Parkinsons disease, the next decision is whether a patient should receive medication, which depends on the following: The degree of functional impairment The degree of cognitive impairment Ability to tolerate antiparkinsonian medication The advice of the attending doctor No two patients react the same way to a given drug, therefore, it takes time and patience to find an appropriate medication and dosage to alleviate symptoms Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s Treatment Options | Johns Hopkins Medicine

Diagnosis and Treatment of Parkinson Disease: A Review

Posted: Published on January 13th, 2022

Importance: Parkinson disease is the most common form of parkinsonism, a group of neurological disorders with Parkinson disease-like movement problems such as rigidity, slowness, and tremor. More than 6 million individuals worldwide have Parkinson disease Continue reading

Posted in Parkinson's Treatment | Comments Off on Diagnosis and Treatment of Parkinson Disease: A Review

Parkinson’s life expectancy: Stages and treatment options

Posted: Published on January 13th, 2022

Parkinsons disease is a progressive disorder of the nervous system. It affects a persons movement and mental ability, with the symptoms getting worse over time. Today, most people with Parkinsons disease will live as long, or almost as long, as those without the disease Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s life expectancy: Stages and treatment options

Parkinsons disease: Light at the end of the tunnel for sufferers of Parkinsons symptoms, with new infrared treatment trials – 7NEWS

Posted: Published on January 13th, 2022

A new treatment for life-robbing Parkinsons disease is set to be trialled in Sydney following reports of good results using light therapy. Results from a previous light therapy trial in Adelaide published in the BMC Neurology journal, showed enhanced senses and improved cognition, mood and sleep, mobility, balance, and fine motor skills among patients. Watch the video above to find out how the new life-changing technology uses waves of light to treat Parkinsons sufferer Margaret Jarrett The SYMBYX trial conducted with Parkinsons SA, used the light therapy known as photobiomodulation (PBM) on two small groups of patients, all diagnosed with Parkinsons disease. Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinsons disease: Light at the end of the tunnel for sufferers of Parkinsons symptoms, with new infrared treatment trials – 7NEWS

Enterin and Their Collaborators at NIH Announce That Alpha-Synuclein, the Culprit in Parkinson’s Disease, is Core and Central to Normal Immune…

Posted: Published on January 13th, 2022

PHILADELPHIA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- EnterinInc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, announces the publication of a paper entitled "Alpha-synuclein, the culprit in Parkinson's Disease, is required for normal immune function." Alpha-synuclein (S), the pathologic protein associated with Parkinson's Disease (PD), appears to be essential for the immune protection of the abdominal cavity.Furthermore, infections in the GI tract can cause accumulation ofSwithin the entire nervous system, potentially contributing to the development and/or progression of PD,according to scientists at the National Institutes of Health (NIH) and their colleagues, the founders of Enterin, Inc Continue reading

Posted in Parkinson's Treatment | Comments Off on Enterin and Their Collaborators at NIH Announce That Alpha-Synuclein, the Culprit in Parkinson’s Disease, is Core and Central to Normal Immune…

Parkinson’s Disease Treatment Market Size, Share, Application Analysis, Regional Outlook, Trends, Competitive Strategies and Forecasts to 2029 -…

Posted: Published on January 13th, 2022

The superior Parkinsons Disease Treatment market analysis report contains all the company profiles of the major players and brands. Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s Disease Treatment Market Size, Share, Application Analysis, Regional Outlook, Trends, Competitive Strategies and Forecasts to 2029 -…

Vaxxinity Awarded Grant from The Michael J. Fox Foundation – GlobeNewswire

Posted: Published on January 13th, 2022

DALLAS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc Continue reading

Posted in Parkinson's Treatment | Comments Off on Vaxxinity Awarded Grant from The Michael J. Fox Foundation – GlobeNewswire

Washington County Attorney Pete Orput to retire at end of the year – Minneapolis Star Tribune

Posted: Published on January 13th, 2022

Washington County Attorney Pete Orput will not seek re-election for a fourth term and plans to retire at the end of this year, he said Friday. The announcement comes more than year after Orput, 66, publicly revealed that he had been diagnosed with Parkinson's disease. He was first elected Washington County attorney in 2010. Continue reading

Posted in Parkinson's Treatment | Comments Off on Washington County Attorney Pete Orput to retire at end of the year – Minneapolis Star Tribune

Page 276«..1020..275276277278..290300..»